Luigi Claudio
Impact in
-
- Chemokine receptors and signaling
- Cancer-related Molecular Pathways
- CAR-T cell therapy research
-
- Heavy Metal Exposure and Toxicity
Papers in
- Surgery 5
- Genital Health and Disease 3
-
- Prostate Cancer Treatment and Research 3
- Co-authors
- Pier Paolo Claudio (5 shared papers)Erik J. Tokar (1 shared paper)Pierpaolo Aimola (1 shared paper)Adrie van Bokhoven (1 shared paper)Anna Rita Volpe (1 shared paper)Michael P. Waalkes (1 shared paper)Marco Carmignani (1 shared paper)Candace M. Howard (2 shared papers)
- Journals
- Molecular Therapy (1 paper)Urology (1 paper)Current Cancer Drug Targets (1 paper)Cancer (1 paper)Current Gene Therapy (1 paper)
- Partner nations
- ItalyUnited States
In The Last Decade
Luigi Claudio
12 papers receiving 360 citations
Peers
Comparison fields: 5 of 70
- Oncology 172
- Health, Toxicology and Mutagenesis 53
- Biotechnology 27
- Urology 18
- Immunology 58
Countries citing papers authored by Luigi Claudio
This map shows the geographic impact of Luigi Claudio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luigi Claudio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luigi Claudio more than expected).
Fields of papers citing papers by Luigi Claudio
This network shows the impact of papers produced by Luigi Claudio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luigi Claudio. The network helps show where Luigi Claudio may publish in the future.
Co-authors
The 25 scholars most cited alongside Luigi Claudio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 72 | |
| 2 | 2009 | 67 | |
| 3 | 2010 | 67 | |
| 4 | Expression of cell-cycle-regulated proteins pRb2/p130, p107, p27(kip1), p53, mdm-2, and Ki-67 (MIB-1) in prostatic gland adenocarcinoma. | 2002 | 62 |
| 5 | 2005 | 23 | |
| 6 | 2007 | 17 | |
| 7 | 2009 | 16 | |
| 8 | 1990 | 14 | |
| 9 | 2013 | 11 | |
| 10 | Intravesical chemo-immunotherapy in non muscle invasive bladder cancer. | 2013 | 10 |
| 11 | [Role of crural inguinal lymphadenectomy and dynamic sentinel lymph node biopsy in lymph node staging in squamous-cell carcinoma of the penis. Our experience]. | 2003 | 6 |
| 12 | 2005 | 2 |
About Luigi Claudio
Luigi Claudio is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Urology, Oncology and Genetics, having authored 12 papers that have together received 367 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (3 papers), Genital Health and Disease (3 papers), Cancer, Lipids, and Metabolism (2 papers), Virus-based gene therapy research (2 papers), Urinary Bladder and Prostate Research (2 papers), Urological Disorders and Treatments (2 papers), Heavy Metal Exposure and Toxicity (1 paper) and Ethics and Legal Issues in Pediatric Healthcare (1 paper). The work is most often cited by research in Oncology (172 citations), Health, Toxicology and Mutagenesis (53 citations), Biotechnology (27 citations), Urology (18 citations) and Immunology (58 citations). Luigi Claudio has collaborated with scholars based in Italy and United States. Frequent co-authors include Pier Paolo Claudio, Erik J. Tokar, Pierpaolo Aimola, Adrie van Bokhoven, Anna Rita Volpe, Michael P. Waalkes, Marco Carmignani, Candace M. Howard, Adelaide Greco and Marco Salvatore. Their work appears in journals such as Molecular Therapy, Urology, Current Cancer Drug Targets, Cancer and Current Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.